...
首页> 外文期刊>Cancer investigation >Centroblastic diffuse large B cell lymphoma displays distinct expression pattern and prognostic role of apoptosis resistance related proteins
【24h】

Centroblastic diffuse large B cell lymphoma displays distinct expression pattern and prognostic role of apoptosis resistance related proteins

机译:中心粒细胞弥漫性大B细胞淋巴瘤表现出独特的表达模式和凋亡抗性相关蛋白的预后作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Centroblastic diffuse large B cell lymphoma (DLBCL) samples were analyzed by immunohistochemistry to evaluate the expression of p53, Bcl-2, Survivin, XIAP, and Ki-67. Survivin was the only protein which expression exhibited a trend for impact in progression-free (p = .077) and overall survival (p = .054). In the MannWhitney test, Survivin expression correlated with a negative overall survival (p = .045). These results appeared to be intimately related to Survivin cytoplasmic localization. Moreover, the anti-apoptotic proteins Bcl-2 and Survivin were less frequent in centroblastic DLBCL. Our results indicate that centroblastic DLBCL may be a disease with characteristic biology and clinical course and, therefore, specific prognostic factors.
机译:通过免疫组织化学分析了离心性弥漫性大B细胞淋巴瘤(DLBCL)样品,以评估p53,Bcl-2,Survivin,XIAP和Ki-67的表达。 Survivin是唯一在无进展(p = .077)和总体生存(p = .054)中表现出影响趋势的蛋白质。在MannWhitney测试中,Survivin表达与总生存期负相关(p = .045)。这些结果似乎与Survivin细胞质定位密切相关。此外,抗凋亡蛋白Bcl-2和Survivin在中心粒性DLBCL中的频率较低。我们的结果表明,成粒细胞DLBCL可能是具有特征生物学和临床过程,因此具有特定预后因素的疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号